Abstract: The present disclosure relates to an external pressure type hollow fiber membrane component, a filtration membrane component, and a membrane filtration assembly, and provides an external pressure type hollow fiber membrane component, comprising: a housing having an inner cavity; and two end parts respectively provided at two ends of the inner cavity of the housing, the end parts being provided with a plurality of void passages running through the end parts in the axial direction of the housing and a plurality of water collection passages communicated with each other, and the void passages and the water collection passages are staggered at intervals. The present disclosure also provides a filtration membrane component and a membrane filtration assembly.

Abstract: Provided in the present disclosure is a fused protein. The fused protein comprises a plurality of target protein sequences, which are connected in series, wherein every two adjacent target protein sequences are connected by means of a linker sequence, the linker sequence is suitable for being cut into a plurality of free target proteins by means of protease, the multiple target protein sequences are not cleaved by the protease, and neither the C-terminus nor the N-terminus of the free target proteins contains additional residues.

Abstract: A packet processing method includes generating, by a processor of a network device, a first encoding task based on M original packets in a to-be-processed first data stream, where M is a positive integer, and where the first encoding task instructs to encode the M original packets; and performing, by a target hardware engine of the network device and based on the first encoding task, forward error correction (FEC) encoding on the M original packets to obtain R redundant packets, where R is a positive integer.

Abstract: A method for issuing a quantum key chip, a method for applying a quantum key chip, an issuing platform and a system. The method comprises: feeding, by a a quantum key issuing platform, a quantum key into a quantum key chip and binding an ID of the quantum key chip in a one-to-one correspondence to an ID of a user using the quantum key chip, where the ID of the quantum key chip and/or the ID of the user serve as identification information of the quantum key in the quantum key chip, and the quantum key is obtained by pre-negotiation between the quantum key issuing platform and a key distribution center (KDC); and sending, by the quantum key issuing platform, the identification information of the quantum key to the KDC, so that the KDC binds the identification information to the quantum key corresponding to the identification information.

Abstract: In a packet processing method, concatenation processing is performed on other original packets other than a largest first packet in a plurality of original packets. Padding processing is performed on a concatenated packet only when a size of the concatenated packet is less than a size of a largest packet, without performing padding processing on each of the other original packets.

Abstract: Disclosed herein are 4-amino-5-(cyclohexyloxy)quinoline-3-carboxylic acid compounds having useful as sweet flavor modifiers. Also disclosed herein are ingestible compositions that include one or more of these compounds in combination with a natural or artificial sweetener.

Abstract: A method, computer program product and computer system to generate a spatial visualization of topics contained in messages data is provided. A processor retrieves message data associated with a user. A processor determines one or more topics represented by the message data. A processor generates a spatial visualization of one or more user interface elements, where the spatial visualization includes a size and a location for the one or more user interface elements. A processor displays one or more user interface elements corresponding to the one or more topics.

Abstract: A method, computer program product and computer system to generate a spatial visualization of topics contained in messages data is provided. A processor retrieves message data associated with a user. A processor determines one or more topics represented by the message data. A processor generates a spatial visualization of one or more user interface elements, where the spatial visualization includes a size and a location for the one or more user interface elements. A processor displays one or more user interface elements corresponding to the one or more topics.

Abstract: The present invention relates to methods for treating brain metastasis by inhibiting gap junction functionality. It is based, at least in part, on the discovery that cancer cells expressing Protocadherin 7 and Connexin 43 form gap junctions with astrocytes that promote the growth of brain metastases, and that inhibition of Protocadherin 7 and/or Connexin 43 expression in cancer cells reduce progression of brain metastases. It is further based on the discovery that treatment with gap junction inhibitors tonabersat and meclofenamate inhibited progression of brain metastatic lesions and enhanced the anti-cancer activity of the conventional chemotherapeutic agent, carboplatin.

Abstract: The disclosure provides a method and an apparatus for determining a quality grade of video data, and relates to the field of data processing technologies, wherein the method includes: acquiring a plurality of initial EEG data; based on the plurality of initial EEG data, determining an initial EEG data set, wherein the initial EEG data set includes a first sub-data set and a second sub-data set, the first sub-data set is a data set built on the basis of emotional response electroencephalogram data, and the second sub-data set is a data set built on the basis of electroencephalogram emotion data; processing the first sub-data set and the second sub-data set by using a transfer learning algorithm to obtain a third sub-data set and a fourth sub-data set; and based on the third sub-data set and the fourth sub-data set, determining a quality evaluation grade of video data with degraded quality.

Abstract: Provided are methods for identifying the presence or absence of a chromosome abnormality by which a cell-free sample nucleic acid from a subject is analyzed. In certain embodiments, provided are methods for identifying the presence or absence of a fetal chromosome abnormality in a nucleic acid from cell-free maternal blood.

Abstract: An apparatus is provided for auto-locating positions of a plurality of wireless sensors on a vehicle. The apparatus comprises a receiving unit for receiving signals from the plurality of wireless sensors. The apparatus further comprises a processing unit arranged to calculate a probability value for each one of the plurality of wireless sensors based upon signals that have accumulated over a period of time to provide a table of probability values. Each probability value contained in the table during a calculation cycle of the processing unit is indicative of likelihood of one of the plurality of wireless sensors being located at a corresponding one of a plurality of positions on the vehicle. Each one of the plurality of wireless sensors is associated with the position having the highest probability value during the calculation cycle.

Abstract: Provided are an organic compound and an application thereof. The organic compound has a structure as shown in Formula I. The overlap degree between HOMO and LUMO is effectively reduced through structural framework design and specific group introduction, thus the energy level difference between the triplet state and the singlet state is reduced to below 300 meV, the reverse crossing of the energy from the triplet to the singlet is satisfied. The organic compound obtains a relatively balanced radiative transition rate and good TADF characteristics, and has excellent carrier transport performance, balance and stability of electron mobility and hole mobility, low preparation cost, and environmental friendliness. The organic compound can be used as a light-emitting layer material of an OLED device, and the material has a TADF light-emitting mechanism and high light-emitting quantum efficiency, which can reduce the drive voltage and energy consumption, and improve luminous efficiency and working life.

Abstract: A well configuration for co-injection processes, wherein a horizontal producer well at the bottom of the pay is combined with injection or injection and producer wells that are vertical and above the lower horizontal production well. This well arrangement minimizes “blanket” effects by non-condensable gases.

Abstract: The present invention relates to the discovery that certain non-naturally occurring, non-peptide amide compounds and amide derivatives, such as oxalamides, ureas, and acrylamides, are useful flavor or taste modifiers, such as a flavoring or flavoring agents and flavor or taste enhancer, more particularly, savory (the “umami” taste of monosodium glutamate) or sweet taste modifiers, savory or sweet flavoring agents and savory or sweet flavor enhancers, for food, beverages, and other comestible or orally administered medicinal products or compositions.

Abstract: Embodiments of this application provide a data stream transmission method. The method includes a sending device that dynamically determines a packet-loss-concealment policy based on first path status information of a path used to send a data stream. The sending device generates a packet-loss-concealment packet for the data stream according to the packet-loss-concealment policy. The sending device sends the data stream on the path. The data stream includes an original packet and the packet-loss-concealment packet. Therefore, when receiving the data stream, a receiving device decodes the data stream according to the packet-loss-concealment policy received from the sending device, and recovers, by using the packet-loss-concealment packet, an original packet lost in a transmission process. This effectively improves a packet loss recovery effect, and improves user experience.

Abstract: A binocular-vision-based method for tracking fruit space attitude and fruit space motion, the method comprising: establishing a connected base coordinate system by taking a junction of a fruit and a fruit stem as an origin; statically photographing a feature point on the surface of the fruit and a point of the connected base coordinate system established at the junction of the fruit and the fruit stem; storing a photographed image; acquiring an inherent relationship between the feature point and the connected base coordinate system; photographing dynamic motion of the fruit; acquiring absolute coordinates of the feature point on the surface of the fruit; calculating, according to the inherent relationship between the feature point and the connected base coordinate system, absolute coordinates of a point of the connected base coordinate system at each moment corresponding to each frame of image; and respectively calculating the displacement, instantaneous speed and instantaneous acceleration of the fruit, calc

Abstract: Embodiments of this application disclose a chunking method and an apparatus for implementing the method. According to the method provided in the embodiments of this application, a first data segment of a first length may be determined starting from a header of a to-be-chunked data flow, a data distribution characteristic of the first data segment is determined based on character values of all characters in the first data segment, and then a chunking position is determined for different data distribution characteristics by using different methods. In this way, a data flow can be better chunked, so as to enhance a deduplication effect.

Abstract: Provided are methods for identifying the presence or absence of a chromosome abnormality by which a cell-free sample nucleic acid from a subject is analyzed. In certain embodiments, provided are methods for identifying the presence or absence of a fetal chromosome abnormality in a nucleic acid from cell-free maternal blood.

Abstract: This disclosure related to antagonistic dual receptor antigen-binding proteins, e.g. antibodies and methods of using the dual receptor antibodies for treatment of pathological diseases. The dual receptor antibodies may comprise an antibody to ActRII receptors and may be used to treat pathological condition. The pathological conditions can comprise muscle wasting diseases or any disease that requires stimulation of muscle growth.